Impact of metabolic syndrome and metabolic dysfunction-associated fatty liver disease on cardiovascular risk by the presence or absence of type 2 diabetes and according to sex

Global multi-stakeholder endorsement of the MAFLD definition

(2022) Nahum Méndez-Sánchez et al.   Lancet Gastroenterology & Hepatology

Statin use is associated with lower prevalence of advanced liver fibrosis in patients with type 2 diabetes

(2021) Stefano Ciardullo et al.   METABOLISM-CLINICAL AND EXPERIMENTAL

Accuracy of Japanese claims data in identifying diabetes‐related complications

(2021) Kazuya Fujihara et al.   PHARMACOEPIDEMIOLOGY AND DRUG SAFETY

Links between metabolic syndrome and metabolic dysfunction-associated fatty liver disease

(2021) Soo Lim et al.   TRENDS IN ENDOCRINOLOGY AND METABOLISM

Associations of Systolic Blood Pressure and Diastolic Blood Pressure With the Incidence of Coronary Artery Disease or Cerebrovascular Disease According to Glucose Status

(2021) Mayuko Harada Yamada et al.   DIABETES CARE

Hepatic sexual dimorphism — implications for non-alcoholic fatty liver disease

(2021) Philippe Lefebvre et al.   Nature Reviews Endocrinology

Incorporating fatty liver disease in multidisciplinary care and novel clinical trial designs for patients with metabolic diseases

(2021) Mohammed Eslam et al.   Lancet Gastroenterology & Hepatology

Fatty liver index and development of cardiovascular disease in Koreans without pre-existing myocardial infarction and ischemic stroke: a large population-based study

(2020) Jun Hyung Kim et al.   Cardiovascular Diabetology

Women have Lower Risk of Nonalcoholic Fatty Liver Disease but Higher Risk of Progression vs Men: A Systematic Review and Meta-analysis

(2020) Maya Balakrishnan et al.   Clinical Gastroenterology and Hepatology

A new definition for metabolic dysfunction-associated fatty liver disease: An international expert consensus statement

(2020) Mohammed Eslam et al.   JOURNAL OF HEPATOLOGY

Gamma glutamyl transferase – an underestimated marker for cardiovascular disease and the metabolic syndrome

(2020) Manuela G Neuman et al.   JOURNAL OF PHARMACY AND PHARMACEUTICAL SCIENCES

Metabolic Dysfunction-Associated Fatty Liver Disease and Incident Cardiovascular Disease Risk: A Nationwide Cohort Study

(2020) Hokyou Lee et al.   Clinical Gastroenterology and Hepatology

Severity of Nonalcoholic Fatty Liver Disease and Risk of Future Ischemic Stroke Events

(2020) Jie Xu et al.   STROKE

Sex Differences in NAFLD : State of the Art and Identification of Research Gaps

(2019) Amedeo Lonardo et al.   HEPATOLOGY

Prevalence, incidence, and outcome of non-alcoholic fatty liver disease in Asia, 1999–2019: a systematic review and meta-analysis

(2019) Jie Li et al.   Lancet Gastroenterology & Hepatology

Sex differences in cardiometabolic disorders

(2019) Eva Gerdts et al.   NATURE MEDICINE

Non-alcoholic fatty liver disease and risk of incident acute myocardial infarction and stroke: findings from matched cohort study of 18 million European adults

(2019) Myriam Alexander et al.   BMJ-British Medical Journal

Association between Smoking and Liver Fibrosis among Patients with Nonalcoholic Fatty Liver Disease

(2019) Hongjie Ou et al.   Canadian Journal of Gastroenterology and Hepatology

Nonalcoholic Fatty Liver Disease and Fibrosis Associated With Increased Risk of Cardiovascular Events in a Prospective Study

(2019) Francesco Baratta et al.   Clinical Gastroenterology and Hepatology

Characteristic Features of Nonalcoholic Fatty Liver Disease in Japan with a Focus on the Roles of Age, Sex and Body Mass Index

(2019) Maki Tobari et al.   Gut and Liver

Synergistic increase in cardiovascular risk in diabetes mellitus with nonalcoholic fatty liver disease

(2018) Yao-Yao Zhou et al.   EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY

The cut-off values of surrogate measures for insulin resistance in the Korean population according to the Korean Genome and Epidemiology Study (KOGES)

(2018) Bongyoung Kim et al.   PLoS One

The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases

(2017) Naga Chalasani et al.   HEPATOLOGY

Asia-Pacific Working Party on Non-alcoholic Fatty Liver Disease guidelines 2017-Part 1: Definition, risk factors and assessment

(2017) Vincent Wai-Sun Wong et al.   JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY

Non-alcoholic fatty liver disease and risk of incident cardiovascular disease: A meta-analysis

(2016) Giovanni Targher et al.   JOURNAL OF HEPATOLOGY

Clinical Model for NASH and Advanced Fibrosis in Adult Patients With Diabetes and NAFLD: Guidelines for Referral in NAFLD

(2015) Jessica Bazick et al.   DIABETES CARE

Liver Fibrosis, but No Other Histologic Features, Is Associated With Long-term Outcomes of Patients With Nonalcoholic Fatty Liver Disease

(2015) Paul Angulo et al.   GASTROENTEROLOGY

Screening diabetic patients for non-alcoholic fatty liver disease with controlled attenuation parameter and liver stiffness measurements: a prospective cohort study

(2015) Raymond Kwok et al.   GUT

NAFLD: A multisystem disease

(2015) Christopher D. Byrne et al.   JOURNAL OF HEPATOLOGY

Performance and limitations of steatosis biomarkers in patients with nonalcoholic fatty liver disease

(2014) L. Fedchuk et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Nonalcoholic fatty liver disease, hepatic insulin resistance, and type 2 Diabetes

(2013) Andreas L. Birkenfeld et al.   HEPATOLOGY

Hyperinsulinemia and the Development of Nonalcoholic Fatty Liver Disease in Nondiabetic Adults

(2010) Eun-Jung Rhee et al.   AMERICAN JOURNAL OF MEDICINE

Visceral Adiposity Index: A reliable indicator of visceral fat function associated with cardiometabolic risk

(2010) M. C. Amato et al.   DIABETES CARE

Development of a Database of Health Insurance Claims: Standardization of Disease Classifications and Anonymous Record Linkage

(2010) Shinya Kimura et al.   JOURNAL OF EPIDEMIOLOGY

The Metabolic Syndrome and Cardiovascular Risk

(2010) Salvatore Mottillo et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Harmonizing the Metabolic Syndrome

(2009) K.G.M.M. Alberti et al.   CIRCULATION